Isomorphic Chief Executive Officer Demis Hassabis said that the lab plans to use the new capital to accelerate its move toward clinical trials.
Alphabet's Isomorphic Labs Raises $5 Billion In Sequoia-Led Funding Round
Published ·

Keep reading
Related stories




